Story
Securitas Shares Plunge to Two-Year Low After Organic Growth Stalls

Summary
Securitas AB shares fell over 11% after the company's second-quarter report revealed that organic sales growth had completely halted at 0%, raising investor concerns about its growth trajectory.
Shares of Securitas AB (STO:SECU-B) plunged 11.4% in recent trading to SEK 150.30, their lowest level in approximately two years, after the company's second-quarter 2026 interim report signaled an abrupt halt to its growth momentum.
Growth Concerns Mount
The primary catalyst for the sell-off was the revelation that organic sales growth stalled at 0% for the quarter. This figure marks a sharp deceleration from the 5% growth reported in the same period of the prior year. The company's top line also contracted, with quarterly revenue slipping to SEK 37.84 billion from SEK 38.56 billion year-over-year.
These disappointing growth figures overshadowed several otherwise positive metrics in the report. The company noted that:
- Its adjusted operating margin edged higher to 7.6% from 7.5%.
- Earnings per share rose by 7% during the quarter.
- Cash generation remained solid.
AdMarket Impact and Analyst View
Investors focused heavily on the negative top-line trends, sending the stock to a multi-year low on the Nasdaq Stockholm. The move was a significant underperformance compared to the broader Swedish market, which gained 0.4% during the session, indicating the sell-off was driven by company-specific factors.
According to Investing.com, analysts at Morgan Stanley argued that the results raise doubts about Securitas' ability to sustain its growth narrative. The combination of stalled organic growth and a cautious analyst outlook appeared to create a powerful negative catalyst for the security services provider.
Read next
More on Stocks
Insider Disclosures Show Major Buy at Goosehead, $58M Sale at Aspen Aerogels
Recent SEC filings revealed significant insider transactions, highlighted by a $7.1 million purchase of Goosehead Insurance stock by a major shareholder and a $58.1 million sale of Aspen Aerogels shares by an institutional owner.

Costco Stock Stalls Despite Earnings Beat as High Valuation Weighs on Sentiment
Costco reported quarterly revenue and profit that topped Wall Street estimates, but its shares remained flat as investors focused on a normalizing growth outlook and the stock's premium valuation.

Evonik Shares Surge Over 8% on Report of BASF Merger Approach
Shares in German specialty chemicals firm Evonik Industries jumped after a Financial Times report stated that rival BASF has made a formal merger proposal. The news sparked takeover speculation, pushing the stock to a new 52-week high.

Atlas Energy Stock Surges on $613.5 Million AI Data Center Power Deal
Shares of Atlas Energy Solutions soared after the company announced significant equipment and cost-reimbursement agreements with a major AI firm to develop power infrastructure for data centers.